🔎 Trials Near Me

Dachaigh › Leukemia myeloid geur › Kansas › Overland Park

Sgrùdaidhean clionaigeach Leukemia myeloid geur ann an Overland Park, KS

Tha aon sgrùdadh airson Leukemia myeloid geur a’ lorg phàirtichean aig làrach ann no faisg air Overland Park. Fosglaidh e gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

A’ fastadhÌre 2
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • University of Kansas Clinical Research Center, Fairway · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05564390

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

A’ fastadhÌre 2
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • University of Kansas Clinical Research Center, Fairway · 3 mìle air falbh
Aoisean 18 gu 59 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

A’ fastadhÌre 2
  • University of Kansas Clinical Research Center, Fairway · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

A’ fastadhÌre 2
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • University of Kansas Clinical Research Center, Fairway · 3 mìle air falbh
Aoisean 18 gu 59 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

A’ fastadhÌre 2
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • University of Kansas Clinical Research Center, Fairway · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06317649

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

A’ fastadhÌre 3
  • US-Kansas City KS-KUMC, Fairway · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT06652438

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

A’ fastadhÌre 1
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • University of Kansas Clinical Research Center, Fairway · 3 mìle air falbh
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT05886049

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

A’ fastadhÌre 1
  • The University of Kansas Medical Center Research Institute, Fairway · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Màrt 2026 · NCT05735184

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

A’ fastadhÌre 1
  • University of Kansas, Fairway · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Cèit 2025 · NCT06634394

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

A’ fastadhÌre 2
  • University of Kansas Cancer Center, Fairway · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Màrt 2025 · NCT02781883

Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02

A’ fastadhÌre 1
  • University of Kansas Cancer Center, Fairway · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Ògmh 2020 · NCT04167696

Sgrùdaidhean Leukemia myeloid geur ann am bailtean eile

Sgrùdaidhean eile ann an Overland Park

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.